Xintiandi announced on December 9 that the company received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for ferrous fumarate APIs approved and issued by the State Drug Administration. Ferrous fumarate is an iron agent used to prevent and treat iron deficiency anemia. It improves hemoglobin synthesis and relieves symptoms related to anemia through iron supplementation.

Xintiandi announced on December 9 that the company received the “Notice of Approval of the Marketing Application for Chemical Ingredients” for ferrous fumarate APIs approved and issued by the State Drug Administration. Ferrous fumarate is an iron agent used to prevent and treat iron deficiency anemia. It improves hemoglobin synthesis and relieves symptoms related to anemia through iron supplementation.